# China Grand Pharmaceutical and CDH Genetech clear CFIUS for Sirtex Medical acquisition

China Grand Pharmaceutical and Healthcare Holdings Limited and CDH Genetech, Ltd. received CFIUS clearance for their joint acquisition of Sirtex Medical Limited, an Australian medical device company, for approximately A$1.9 billion (US$1.4 billion).

- Type: Acquisition
- Announced: 2019-03-12
- Where: Australia
- Value: $1.40B (1.90B AUD)
- Status: completed
- Products: oncology treatments for liver cancers using small particle technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [China Grand Pharmaceutical and Healthcare](https://endata.com/companies/28136.md) (acquirer)
- [Sirtex Medical](https://endata.com/companies/29756.md) (target)
- [CDH Genetech](https://endata.com/companies/32599.md) (acquirer)

## Sources

- [tradepractitioner.com](https://www.tradepractitioner.com/2019/03/china-grand-pharmaceutical-healthcare-holdings-cdh-genetech-sirtex/), 2019-03-13: "CFIUS determined, following receipt of certain assurances from the parties to the Acquisition, that there were no unresolved national security concerns with respect to the Acquisition."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.